XML 14 R8.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Operating Activities:    
Net income $ 339,918 $ 335,665
Adjustments to reconcile net income to net cash from operating activities:    
Provision for loan losses 25,404 17,846
Deferred tax expense (benefit) (1,625) 39,198
Accretion of loan discounts (11,364) (10,470)
Securities premium amortization (discount accretion), net 84,963 73,748
Net (gain) loss on securities transactions (265) 113
Depreciation and amortization 39,182 37,452
Net (gain) loss on sale/write-down of assets/foreclosed assets (6,016) (6,122)
Stock-based compensation 10,693 9,556
Net tax benefit from stock-based compensation 1,602 3,378
Earnings on life insurance policies (2,744) (2,510)
Net change in:    
Trading account securities (3,132) (1,094)
Lease right-of-use assets 14,618 0
Accrued interest receivable and other assets 37,608 (19,047)
Accrued interest payable and other liabilities 56,354 (17,545)
Net cash from operating activities 585,196 460,168
Investing Activities:    
Securities held-to-maturity - Purchases 0 (1,500)
Securities held to maturity: Maturities, calls and principal repayments 69,273 300,340
Securities available for sale:    
Purchases (9,815,936) (14,983,642)
Sales 8,236,066 13,838,566
Maturities, calls and principal repayments 1,007,783 182,028
Proceeds from sale of loans 24,036 21,318
Net change in loans (569,223) (718,551)
Benefits received on life insurance policies 0 384
Proceeds from sales of premises and equipment 8,019 12,859
Purchases of premises and equipment (168,326) (56,781)
Proceeds from sales of repossessed properties 131 1,106
Net cash from investing activities (1,208,177) (1,403,873)
Financing Activities:    
Net change in deposits (65,622) (523,535)
Net change in short-term borrowings (166,893) (64,047)
Proceeds from stock option exercises 13,506 26,567
Purchase of treasury stock (67,709) (70)
Cash dividends paid on preferred stock (6,047) (6,047)
Cash dividends paid on common stock (132,132) (122,721)
Net cash from financing activities (424,897) (689,853)
Net change in cash and cash equivalents (1,047,878) (1,633,558)
Cash and equivalents at beginning of period 3,955,779 5,053,047
Cash and equivalents at end of period $ 2,907,901 $ 3,419,489